Balyasny Asset Management’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$274K Buy
2024
Q2
Sell
2024
Q1
$356K Sell
2023
Q4
$280K Buy